Welcome to our dedicated page for Innovage Holding news (Ticker: INNV), a resource for investors and traders seeking the latest updates and insights on Innovage Holding stock.
InnovAge Holding Corp (INNV) operates a specialized healthcare platform delivering integrated care for seniors through the PACE program. This page aggregates official company announcements, financial disclosures, and operational updates for investors and industry observers.
Access timely press releases covering earnings reports, care model innovations, regulatory developments, and strategic partnerships. Our curated collection helps stakeholders track INNV's performance in senior care markets while monitoring implementation of their capitated payment model.
Key updates include Medicare/Medicaid compliance changes, center expansions, clinical quality improvements, and leadership announcements. Bookmark this page for centralized access to verified InnovAge communications, maintained with neutral reporting standards.
InnovAge Holding Corp. (Nasdaq: INNV) announced that CEO Maureen Hewitt will present at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 8:15 p.m. (ET). The event will feature a virtual fireside chat with key executives, including Patrick Blair, President, and Barb Gutierrez, CFO. InnovAge specializes in delivering comprehensive healthcare programs tailored for frail, dual-eligible seniors, aiming to enhance care quality while minimizing costs. As of September 30, 2021, the company served approximately 6,990 participants across 18 centers in five states.
Glancy Prongay & Murray LLP announces a class action lawsuit opportunity for InnovAge Holding Corp investors following significant losses. The relevant period is the March 2021 IPO, with a lead plaintiff deadline of December 13, 2021. Allegations include failure to disclose inadequate services provided by InnovAge facilities and potential regulatory scrutiny from the Centers for Medicare and Medicaid Services, risking suspension of new enrollments. Investors are encouraged to contact GPM for more information on their rights and the lawsuit process.
InnovAge Holding Corp. (NASDAQ: INNV) faces a securities fraud class action lawsuit initiated by investors. The class period began with the company's IPO in March 2021, and investors have until December 13, 2021, to take action. Allegations claim that InnovAge failed to disclose critical operational issues, including inadequate services and potential regulatory scrutiny from the Centers for Medicare and Medicaid Services. These omissions may have misled investors regarding the company's financial stability and growth prospects.
Investors in InnovAge Holding Corp (INNV) with substantial losses may lead a securities fraud class action lawsuit, as announced by Glancy Prongay & Murray LLP. The relevant period concerns the company's IPO in March 2021, with a lead plaintiff deadline set for December 13, 2021. The lawsuit alleges that InnovAge failed to disclose critical service inadequacies and risks of regulatory scrutiny from CMS, which could affect operations and enrollment. Stakeholders are encouraged to submit their contact information for participation in the lawsuit.
InnovAge Holding Corp. (Nasdaq: INNV) appointed Patrick Blair as President, effective Dec. 1, 2021. Blair will manage operations and implement growth plans, which include opening three new sites in fiscal year 2023. He brings extensive experience from leadership roles in healthcare, including BAYADA Home Health Care and Anthem. The board expressed confidence in Blair's ability to enhance InnovAge's operational capabilities and drive profitable growth in the senior healthcare market. As of September 30, 2021, InnovAge serves nearly 7,000 participants across 18 centers in five states.
InnovAge Holding Corp. (Nasdaq: INNV) has received approval from Indiana to launch a Program of All-Inclusive Care for the Elderly (PACE) in Terre Haute, expanding its service area and potentially benefiting 79% of eligible seniors in the state. The new center is expected to open in fiscal year 2024, aiming to enroll over 600 seniors and create 100 local healthcare jobs. InnovAge's analysis estimates around 3,000 PACE-eligible seniors in the region by 2026, enhancing its footprint in the senior care market amidst increasing demand.
InnovAge Holding Corp. (Nasdaq: INNV) reported fiscal Q1 2022 results, highlighting total revenues of $173.1 million, reflecting a 13.4% year-over-year increase. The number of participants grew by 7.2% to 6,990. Center-level contribution margin reached $42.3 million, a 4.3% increase, though as a percentage of revenue, it declined by 2.2 percentage points due to normalized medical costs. Net income stood at $7.6 million compared to a loss of $49.8 million a year prior. InnovAge confirmed its fiscal 2022 guidance, projecting revenues between $712 million and $725 million.
Glancy Prongay & Murray LLP has announced a class action lawsuit for investors of InnovAge Holding Corp (NASDAQ: INNV) who have suffered substantial losses since its IPO in March 2021. The lawsuit arises from allegations that InnovAge failed to disclose critical information regarding its service quality and regulatory scrutiny, potentially leading to suspension of new enrollments by the Centers for Medicare and Medicaid Services. Interested investors can submit their contact information to participate, with a lead plaintiff deadline set for December 13, 2021.
InnovAge Holding Corp. (Nasdaq: INNV) will announce its fiscal Q1 2022 financial results on November 9, 2021, post-market close. A conference call will follow at 5 p.m. E.T. for analysis and discussion of the results. Participants can join by calling U.S. number (833) 398-1024 or international number (914) 987-7722, using code 8193149. InnovAge focuses on managing care for high-cost, dual-eligible seniors, serving around 6,850 participants across 18 centers in five states as of June 30, 2021. The company aims to enhance quality care while reducing high-cost care utilization.
InnovAge Holding Corp. (Nasdaq: INNV) announced strong fiscal fourth quarter and full-year financial results for the year ending June 30, 2021. Total revenues reached $637.8 million, a 12.5% increase year-over-year, driven by a census growth of 7.4% to approximately 6,850 participants. However, the company reported a net loss of $44.7 million for the year. Adjusted EBITDA rose by 29.5% to $85.3 million. InnovAge plans to open new centers in fiscal 2023 and has achieved high vaccination rates among participants and employees. The company projects total revenues between $712 and $725 million for fiscal year 2022.
